Search Results - "Protzer U"

This result is not displayed to guests.
Login for full access.

Control of hepatitis B virus at the level of transcription.

Authors: Quasdorff, M. Protzer, U.

Source: Journal of Viral Hepatitis. Aug2010, Vol. 17 Issue 8, p527-536. 10p. 2 Diagrams.

Can Engineered "Designer" T Cells Outsmart Chronic Hepatitis B?

Authors: Protzer, U. Abken, H.

Source: Hepatitis Research & Treatment. 2010, p1-9. 9p. 1 Diagram, 2 Charts.

The German guideline for the management of hepatitis B virus infection: short version.

Authors: Cornberg, M. Protzer, U. Dollinger, M. M. et al.

Source: Journal of Viral Hepatitis. Sep2008 Supplement 1, Vol. 15, p1-21. 21p. 4 Diagrams, 10 Charts.

Adoptive T-cell therapy as a therapeutic option for chronic hepatitis B.

Authors: Bohne, F. Protzer, U.

Source: Journal of Viral Hepatitis. Nov2007 Supplement 1, Vol. 14, p45-50. 6p. 1 Diagram.

Living in the liver: hepatic infections.

Authors: Protzer U Maini MK Knolle PA et al.

Source: Nature Reviews Immunology. Mar2012, Vol. 12 Issue 3, p201-213. 13p.

Carving the CAR.

Authors: Riddell, S. R. Protzer, U.

Source: Gene Therapy. Oct2010, Vol. 17 Issue 10, p1191-1192. 2p.

Regulation of endotoxin-induced IL-6 production in liver sinusoidal endothelial cells and Kupffer cells by IL-10.

Authors: Knolle, P. A. Löser, E. Protzer, U. et al.

Source: Clinical & Experimental Immunology. Mar1997, Vol. 107 Issue 3, p555-561. 7p.

A proof of concept study for the differentiation of SARS-CoV-2, hCoV-NL63, and IAV-H1N1 in vitro cultures using ion mobility spectrometry.

Authors: Feuerherd, M. Sippel, A.-K. Erber, J. et al.

Source: Scientific Reports. 10/11/2021, Vol. 11 Issue 1, p1-9. 9p.

[419] ANTIVIRAL ACTIVITY AND HEPATOPROTECTION BY HEME OXYGENASE-1 IN MODELS OF HUMAN HEPATITIS B INFECTION

Authors: Protzer, U. Seyfried, S. Quasdorff, M. et al.

Source: Journal of Hepatology. Apr2007, Vol. 46, pS161-S161. 1p.

Improved HBV based vectors for a liver directed gene transfer

Authors: Untergasser, A. Protzer, U.

Source: Journal of Hepatology. Apr2003 Supplement 2, Vol. 38, p4. 1p.

Adenoviral transfer of HBV genomes allows to MIMIC adult and neonatal HBV infection

Authors: Oberwinkler, H. Protzer, U.

Source: Journal of Hepatology. Apr2003 Supplement 2, Vol. 38, p4. 1p.

Clinical and immunological outcomes of SARS-CoV-2-infected vaccine responders, vaccine non-responders, and unvaccinated patients evaluated for neutralizing monoclonal antibody treatment at a single German tertiary care center: a retrospective cohort study with prospective follow-up

Authors: Triebelhorn, J. Schneider, J. Spinner, C. D. et al.

Source: Infection. Jun2024, Vol. 52 Issue 3, p1143-1151. 9p.

Schistosome infection aggravates HCV-related liver disease and induces changes in the regulatory T-cell phenotype.

Authors: Loffredo‐Verde, E. Abdel‐Aziz, I. Albrecht, J. et al.

Source: Parasite Immunology. Feb2015, Vol. 37 Issue 2, p97-104. 11p.

Hepatitis B virus-specific T-cell responses during IFN administration in a small cohort of chronic hepatitis B patients under nucleos(t)ide analogue treatment.

Authors: Sprinzl, M. F. Russo, C. Kittner, J. et al.

Source: Journal of Viral Hepatitis. Sep2014, Vol. 21 Issue 9, p633-641. 9p.

Sequential control of hepatitis B virus in a mouse model of acute, self-resolving hepatitis B.

Authors: John von Freyend, M. Untergasser, A. Arzberger, S. et al.

Source: Journal of Viral Hepatitis. Mar2011, Vol. 18 Issue 3, p216-226. 11p.

MVA-nef induces HIV-1-specific polyfunctional and proliferative T-cell responses revealed by the combination of short- and long-term immune assays.

Authors: Kutscher, S. Allgayer, S. Dembek, C. J. et al.

Source: Gene Therapy. Nov2010, Vol. 17 Issue 11, p1372-1383. 12p. 1 Diagram, 4 Graphs.

Liver-specific expression of interferon?following adenoviral gene transfer controls hepatitis B virus replication in mice.

Authors: Dumortier, J. Schönig, K. Oberwinkler, H. et al.

Source: Gene Therapy. Apr2005, Vol. 12 Issue 8, p668-677. 10p.

Characterization of MHC class II-restricted T-cell receptors for T-cell therapy of HBV infection.

Authors: Schreiber, S. Honz, M. Schiemann, M. et al.

Source: Cytotherapy (Elsevier Inc.). 2019 Supplement, Vol. 21, pS10-S10. 1p.

280 - Transgenic antigen-specific, HLA-A*02:01-allo-restricted cytotoxic T cells recognize and kill tumor associated antigen STEAP1+ tumour cells in vivo.

Authors: Schirmer, D. Grünewald, T. Klar, R. et al.

Source: European Journal of Cancer. Dec2016 Supplement 1, Vol. 69, pS93-S93. 1p.